Clinical Trial Update: Ganciclovir Implant Study for Cytomegalovirus Retinitis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating a ganciclovir implant for cytomegalovirus retinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Cytomegalovirus Retinitis
• HIV Infection

Drugs mentioned

• Ganciclovir implant (ganciclovir)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | Phase 3 | Status: COMPLETED